GlassScriptPhysician profile
Georgia Williams
NPI 1124110465
$8,705.02
in general payments reported to CMS, 2019-2025
46 companies · $884 in 2025
The $884 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,569 · 2022: $1,910 · 2023: $1,305 · 2024: $2,038 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,226.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,271.54 | 2021-2025 | |
| Novo Nordisk INC | $1,196.75 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $960.98 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $600.75 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $482.37 | 2021-2024 | Synjardy, Jardiance, Tradjenta |
| Lilly USA, LLC | $404.44 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $399.81 | 2021-2024 | Veozah |
| Astrazeneca Pharmaceuticals LP | $364.35 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbott Laboratories | $298.78 | 2021-2025 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $243.96 | 2021-2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $229.87 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $184.31 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $160.98 | 2021-2023 | |
| Amgen INC. | $155.57 | 2021-2025 | Evenity |
| Exact Sciences Corporation | $143.42 | 2023-2024 | Cologuard Collection Kit |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgia Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.